Edoxaban vs. Warfarin for Stroke Prevention for Patients with Atrial Fibrillation

被引：0
|
作者：
Diener, H. C.
机构：
来源：
AKTUELLE NEUROLOGIE | 2014年 / 41卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：E52 / E52
页数：1
相关论文
共 50 条
  • [41] EDOXABAN VERSUS WARFARIN ON STROKE RISK IN PATIENTS WITH ATRIAL FIBRILLATION: A TERRITORY-WIDE COHORT STUDY
    Kong, Che Him Dicken
    Zhou, Jiandong
    Lee, Sharen
    Leung, Keith Sai Kit
    Liu, Tong
    Sawant, Abhishek C.
    Corbelli, John
    Wai, Abraham Kc
    Chang, Carlin
    Zhang, Qingpeng
    Tse, Gary
    HEART, 2021, 107 : A149 - A150
  • [42] Edoxaban Versus Warfarin in Patients With Atrial Fibrillation and History of Liver Disease
    Qamar, Arman
    Antman, Elliott M.
    Ruff, Christian T.
    Nordio, Francesco
    Murphy, Sabina A.
    Grip, Laura T.
    Greenberger, Norton J.
    Yin, Ophelia Q. P.
    Choi, Youngsook
    Lanz, Hans J.
    Mercuri, Michele F.
    Braunwald, Eugene
    Giugliano, Robert P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (02) : 179 - 189
  • [43] Cost-Effectiveness of Edoxaban vs. Warfarin in Patients With Atrial Fibrillation: Results From the ENGAGE AF - TIMI 48 Economic Study
    Magnuson, Elizabeth A.
    Vilain, Katherine
    Wang, Kaijun
    Li, Haiyan
    Kwong, Winghan J.
    Antman, Elliott M.
    Ruff, Christian T.
    Guigliano, Robert P.
    Cohen, David J.
    CIRCULATION, 2014, 130
  • [44] Barriers to Warfarin Use for Stroke Prevention in Patients With Atrial Fibrillation in Hong Kong
    Lee, Vivian W. Y.
    Tam, Cheuk Shing
    Yan, Bryan P.
    Yu, Cheuk Man
    Lam, Yat Yin
    CLINICAL CARDIOLOGY, 2013, 36 (03) : 166 - 171
  • [45] Clinical outcomes in patients with atrial fibrillation receiving amiodarone on NOACs vs. warfarin
    Ricardo Avendano
    Jorge Romero
    Florentino Lupercio
    Juan Carlos Diaz
    Renato Quispe
    Anjani Golive
    Andrea Natale
    Mario J. Garcia
    Andrew K. Krumerman
    Luigi Di Biase
    Journal of Interventional Cardiac Electrophysiology, 2019, 54 : 73 - 80
  • [46] Cost-Effectiveness Analysis of Apixaban Versus Edoxaban in Patients with Atrial Fibrillation for Stroke Prevention
    Itziar Oyagüez
    Carmen Suárez
    José Luis López-Sendón
    José Ramón González-Juanatey
    Fernando de Andrés-Nogales
    Jorge Suárez
    Carlos Polanco
    Javier Soto
    PharmacoEconomics - Open, 2020, 4 : 485 - 497
  • [47] Clinical outcomes in patients with atrial fibrillation receiving amiodarone on NOACs vs. warfarin
    Avendano, Ricardo
    Romero, Jorge
    Lupercio, Florentino
    Diaz, Juan Carlos
    Quispe, Renato
    Golive, Anjani
    Natale, Andrea
    Garcia, Mario J.
    Krumerman, Andrew K.
    Di Biase, Luigi
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2019, 54 (01) : 73 - 80
  • [48] Cost-Effectiveness Analysis of Apixaban Versus Edoxaban in Patients with Atrial Fibrillation for Stroke Prevention
    Oyaguez, Itziar
    Suarez, Carmen
    Luis Lopez-Sendon, Jose
    Ramon Gonzalez-Juanatey, Jose
    de Andres-Nogales, Fernando
    Suarez, Jorge
    Polanco, Carlos
    Soto, Javier
    PHARMACOECONOMICS-OPEN, 2020, 4 (03) : 485 - 497
  • [49] Edoxaban for the Prevention of Thromboembolism in Patients With Atrial Fibrillation and Bioprosthetic Valves
    Carnicelli, Anthony P.
    De Caterina, Raffaele
    Halperin, Jonathan L.
    Renda, Giulia
    Ruff, Christian T.
    Trevisan, Marco
    Nordio, Francesco
    Mercuri, Michele F.
    Antman, Elliott
    Giugliano, Robert P.
    CIRCULATION, 2017, 135 (13) : 1273 - 1275
  • [50] Efficacy and safety of edoxaban vs. warfarin in patients with atrial fibrillation and hepatic disease: Insights from the ENGAGE AF-TIMI 48 trial
    Qamar, A.
    Antman, E. A.
    Ruff, C. T.
    Murphy, S. A.
    Nordio, F.
    Choi, Y.
    Lanz, H.
    Mercuri, M. F.
    Braunwald, E.
    Giugliano, R. P.
    EUROPEAN HEART JOURNAL, 2017, 38 : 766 - 767
12345